199 related articles for article (PubMed ID: 23578666)
1. The role of citrullination of an immunodominant proteoglycan (PG) aggrecan T cell epitope in BALB/c mice with PG-induced arthritis.
Misják P; Bősze S; Horváti K; Pásztói M; Pálóczi K; Holub MC; Szakács F; Aradi B; György B; Szabó TG; Nagy G; Glant TT; Mikecz K; Falus A; Buzás EI
Immunol Lett; 2013 Apr; 152(1):25-31. PubMed ID: 23578666
[TBL] [Abstract][Full Text] [Related]
2. Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
Markovics A; Ocskó T; Katz RS; Buzás EI; Glant TT; Mikecz K
PLoS One; 2016; 11(7):e0160284. PubMed ID: 27466816
[TBL] [Abstract][Full Text] [Related]
3. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
[TBL] [Abstract][Full Text] [Related]
4. Induction of arthritis in SCID mice by T cells specific for the "shared epitope" sequence in the G3 domain of human cartilage proteoglycan.
Hanyecz A; Bárdos T; Berlo SE; Buzás E; Nesterovitch AB; Mikecz K; Glant TT
Arthritis Rheum; 2003 Oct; 48(10):2959-73. PubMed ID: 14558103
[TBL] [Abstract][Full Text] [Related]
5. Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis.
von Delwig A; Locke J; Robinson JH; Ng WF
Arthritis Rheum; 2010 Jan; 62(1):143-9. PubMed ID: 20039419
[TBL] [Abstract][Full Text] [Related]
6. Molecular manipulation with the arthritogenic epitopes of the G1 domain of human cartilage proteoglycan aggrecan.
Murad YM; Szabó Z; Ludányi K; Glant TT
Clin Exp Immunol; 2005 Nov; 142(2):303-11. PubMed ID: 16232217
[TBL] [Abstract][Full Text] [Related]
7. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
[TBL] [Abstract][Full Text] [Related]
8. Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.
Glant TT; Radacs M; Nagyeri G; Olasz K; Laszlo A; Boldizsar F; Hegyi A; Finnegan A; Mikecz K
Arthritis Rheum; 2011 May; 63(5):1312-21. PubMed ID: 21305522
[TBL] [Abstract][Full Text] [Related]
9. Differential recognition of altered peptide ligands distinguishes two functionally discordant (arthritogenic and nonarthritogenic) autoreactive T cell hybridoma clones.
Buzás EI; Hanyecz A; Murad Y; Hudecz F; Rajnavölgyi E; Mikecz K; Glant TT
J Immunol; 2003 Sep; 171(6):3025-33. PubMed ID: 12960328
[TBL] [Abstract][Full Text] [Related]
10. The influence of MHC class II molecules containing the rheumatoid arthritis shared epitope on the immune response to aggrecan G1 and its peptides.
Brintnell W; Bell DA; Hill JA; Jevnikar AM; Sette A; Sidney J; Doege K; Cairns E
Scand J Immunol; 2007 May; 65(5):444-52. PubMed ID: 17444955
[TBL] [Abstract][Full Text] [Related]
11. Arthritis induced by proteoglycan aggrecan G1 domain in BALB/c mice. Evidence for t cell involvement and the immunosuppressive influence of keratan sulfate on recognition of t and b cell epitopes.
Zhang Y; Guerassimov A; Leroux JY; Cartman A; Webber C; Lalic R; de Miguel E; Rosenberg LC; Poole AR
J Clin Invest; 1998 Apr; 101(8):1678-86. PubMed ID: 9541498
[TBL] [Abstract][Full Text] [Related]
12. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis.
Buzás EI; Végvári A; Murad YM; Finnegan A; Mikecz K; Glant TT
Cell Immunol; 2005 Jun; 235(2):98-108. PubMed ID: 16185673
[TBL] [Abstract][Full Text] [Related]
13. Naive transgenic T cells expressing cartilage proteoglycan-specific TCR induce arthritis upon in vivo activation.
Berlo SE; van Kooten PJ; Ten Brink CB; Hauet-Broere F; Oosterwegel MA; Glant TT; Van Eden W; Broeren CP
J Autoimmun; 2005 Nov; 25(3):172-80. PubMed ID: 16257179
[TBL] [Abstract][Full Text] [Related]
14. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
[TBL] [Abstract][Full Text] [Related]
15. Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis.
Glant TT; Mikecz K
Methods Mol Med; 2004; 102():313-38. PubMed ID: 15286393
[TBL] [Abstract][Full Text] [Related]
16. Cartilage proteoglycan aggrecan epitopes induce proinflammatory autoreactive T-cell responses in rheumatoid arthritis and osteoarthritis.
de Jong H; Berlo SE; Hombrink P; Otten HG; van Eden W; Lafeber FP; Heurkens AH; Bijlsma JW; Glant TT; Prakken BJ
Ann Rheum Dis; 2010 Jan; 69(1):255-62. PubMed ID: 19213744
[TBL] [Abstract][Full Text] [Related]
17. Selection of self-reactive peptides within human aggrecan by use of a HLA-DRB1*0401 peptide binding motif.
Boots AM; Verheijden GF; Schöningh R; van Staveren CJ; Bos E; Elewaut D; de Keyser F; Veys E; Joosten I; Rijnders AW
J Autoimmun; 1997 Dec; 10(6):569-78. PubMed ID: 9451596
[TBL] [Abstract][Full Text] [Related]
18. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice.
Buzás EI; Brennan FR; Mikecz K; Garzó M; Negroiu G; Holló K; Cs-Szabó G; Pintye E; Glant TT
J Immunol; 1995 Sep; 155(5):2679-87. PubMed ID: 7544381
[TBL] [Abstract][Full Text] [Related]
19. Proteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritis.
Hanyecz A; Olasz K; Tarjanyi O; Nemeth P; Mikecz K; Glant TT; Boldizsar F
Biomed Res Int; 2014; 2014():942148. PubMed ID: 24605340
[TBL] [Abstract][Full Text] [Related]
20. Citrullinated mouse collagen administered to DBA/1J mice in the absence of adjuvant initiates arthritis.
Thiele GM; Duryee MJ; Dusad A; Hunter CD; Lacy JP; Anderson DR; Wang D; O'Dell JR; Mikuls TR; Klassen LW
Int Immunopharmacol; 2012 Aug; 13(4):424-31. PubMed ID: 22626832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
